Free tool: see what your practice is really worth, and what would raise it. Try it →

A buyer sits down across from you and says something like this: "We are looking at a multiple on adjusted EBITDA. We will run a QoE, negotiate a working capital peg, and want you to roll 20 percent. Reps and warranties will be capped at the escrow, and we will need a two-year non-compete inside 15 miles."

That was one sentence. It contained at least eight terms most practice owners have never used before. And every one of them affects your outcome by hundreds of thousands of dollars.

The gap between what buyers say and what owners understand is where most bad deals happen. Not because buyers are dishonest. Because the terminology is unfamiliar, and asking questions feels like admitting you do not know what you are doing.

Here is the plain English version. Every term a buyer will use, what it actually means, and what to watch for.

Valuation Terms

How the buyer arrives at a price.

EBITDA

Earnings Before Interest, Taxes, Depreciation, and Amortization. In practice, it means: your profit before the accountant subtracts loan interest, income taxes, and equipment depreciation. It is the number every buyer uses as the starting point.

Example: Your practice does $2.4M in collections. After paying staff, rent, supplies, lab, and yourself a market-rate salary, you have $600K left. That $600K is your EBITDA.

Adjusted EBITDA

Your EBITDA plus expenses that would not exist under a new owner. Things like your family member on payroll who does not really work, personal expenses run through the practice, a company car you use personally, or the $30K you paid your spouse for administrative work she does not actually do.

Example: Your reported EBITDA is $600K. You add back $40K (family member on payroll), $20K (personal vehicle), $15K (personal travel), and $25K (owner salary above market rate). Adjusted EBITDA is $700K.

Multiple

The multiple applied to your Adjusted EBITDA determines your headline valuation. Multiples vary significantly by practice size, specialty, provider structure, and payer mix. Any published range you see is a directional starting point, not a guarantee. What actually matters is the multiple applied to your specific practice by a specific buyer.

Example: Adjusted EBITDA of $700K at a 6x multiple = $4.2M enterprise value.

Cash at Close

The actual dollars in your account on closing day. Cash at close is the single most important number to understand in any offer because it is the money you can spend, invest, or use for what comes next. Cash at close is almost always lower than the "headline" multiple a buyer quotes because rollover equity, escrow, and earnout components are separated out. Always ask any buyer specifically what your cash-at-close number will be.

Total Contingent Value

Cash at close plus rollover equity plus earnout at target. This is the number that appears in press releases and marketing because it is the largest defensible number in the deal. Rollover and earnout components have real potential value but they are conditional on what happens to the buyer's business and your practice's performance post-close. Understanding the difference between total contingent value and cash at close is the difference between understanding your deal and being surprised by it later.

Add-Backs

The specific expenses being added back to arrive at Adjusted EBITDA. Buyers scrutinize every add-back. Anything without documentation gets stripped out.

Things to verify: Have documentation ready for every add-back. Owner salary add-back should be based on what an associate would actually cost to hire in your market, not what feels right.

Specialty Premium

The higher multiple that specialty practices (orthodontic, pediatric, oral surgery) typically earn compared to general dentistry at the same size tier. The premium exists because specialty revenue is more predictable (contract-based for ortho, recall-based for pediatric) and per-procedure margins are higher (especially oral surgery). Specialty premiums can be reduced by payer mix (heavy Medicaid compresses pediatric premiums specifically) and referral concentration (a specialty practice dependent on one referring source gets discounted regardless of specialty).

Quality of Earnings (QoE)

A third-party accounting firm the buyer hires to verify your financials. They will reconcile bank deposits to reported revenue, examine payroll, test add-backs, and look for anything that would make your numbers unreliable.

Example: The QoE firm sends 40 pages of requests, spends three weeks on your books, and delivers a report. Common outcome: adjusted EBITDA gets reduced by 5 to 15 percent from what you presented. Prepare for this.

Deal Structure Terms

How the purchase price gets divided and paid.

Enterprise Value vs Equity Value

Enterprise Value is the total price for the business. Equity Value is what you actually take home, after subtracting any debt and adjusting for working capital.

Example: $4.2M enterprise value. Subtract $200K of practice debt. Subtract $50K working capital shortfall. Equity value: $3.95M. That is your actual proceeds before taxes.

Working Capital Peg

The amount of cash and receivables the practice needs to keep operating normally the day after close. Set by the buyer, negotiated with the seller. Every dollar the practice has below the peg comes out of your proceeds. Every dollar above goes back to you.

Example: Working capital peg is set at $150K. At close, the practice has $120K in the bank plus receivables. Your proceeds drop by $30K.

The purpose of a working capital peg is fairness for both parties. It prevents the seller from draining working capital right before close, and it prevents the buyer from claiming shortfalls that were actually normal fluctuations. A thoughtful working capital peg calculated from real historical averages is one of the cleaner mechanisms in any deal structure.

Rollover Equity

Instead of taking all cash at close, you keep an ownership stake in the buyer's larger group. Common in DSO deals. The theory is you get a "second bite of the apple" when the DSO eventually sells or grows.

Example: Purchase price $4.2M. You roll 20 percent (($840K) into equity of the buyer's DSO. You take $3.36M in cash and own $840K of the DSO. If the DSO doubles in value in 5 years, your $840K becomes $1.68M.

Things to verify: Rollover equity is only as good as the buyer's business. Ask how they value the equity you are receiving. Ask what happens if you leave, if they sell, or if things go badly.

A well-structured rollover keeps the selling doctor invested in the group's continued success. When both parties execute well post-close, rollover can meaningfully increase the total realized value of the transaction. The doctor becomes a shareholder in the group they helped build. That structure works when you actually want to be part of what the group is building over the next several years.

Earnout

Part of the purchase price paid over time, contingent on the practice hitting certain performance targets after close.

Example: $4.2M total price. $3.5M at close. $700K earnout paid over 3 years, contingent on practice EBITDA maintaining 90 percent of pre-close levels.

A well-structured earnout aligns the buyer and seller around the same outcome: growing the practice successfully after close. The right target is one both parties believe is attainable with good execution, and both understand may take real work to hit. Earnout targets that are set too high (often because a seller pushed hard on the cash-at-close portion) can create misalignment. Earnout targets that are set thoughtfully create shared motivation.

Things to verify: Earnouts often do not pay out fully. Once you no longer control the practice, the buyer controls the numbers. Push for as much cash at close as possible, and negotiate earnout terms that measure things you can influence.

Escrow / Holdback

A portion of your proceeds held back by the buyer for 12 to 24 months to cover potential issues that surface after close. Standard is 5 to 10 percent of the deal.

Example: $4.2M deal. $420K goes into escrow at close. Released to you 18 months later, minus any valid claims by the buyer.

Most escrows get released in full at the end of the holdback period. Buyers get real protection if something surfaces after close. Both sides know how it works going in, which takes the fight out of the closing conversation.

Legal and Protection Terms

Documents and provisions that govern what happens if something goes wrong.

Letter of Intent (LOI)

A non-binding document that outlines the basic terms of the deal. Signing it typically starts an exclusivity period where you cannot talk to other buyers.

Things to verify: The LOI locks you out of the market. Only sign one when you are seriously ready to move forward, and negotiate the important terms (price, structure, exclusivity length) before signing, not after.

Definitive Agreement (APA or SPA)

The binding purchase document. Asset Purchase Agreement (APA) if the buyer is buying the practice's assets. Stock Purchase Agreement (SPA) if buying your entity's shares. Both are 60 to 100+ pages long.

Reps and Warranties

Statements you make in the definitive agreement about the practice. Things like "the financials are accurate," "there is no pending litigation," "all employees are properly classified," "all equipment is owned or leased legitimately."

Example: You represent that there are no undisclosed HIPAA violations. Six months after close, a former patient files a complaint about something that happened before close. Because you represented there were none, you are on the hook for the cost.

Reps and warranties exist to create shared expectations about what the buyer is acquiring. When they are clear and reasonable, they protect both parties. The seller is confirming what they know to be true. The buyer is committing to accept the business as represented. Well-crafted reps and warranties reduce post-close disputes because both parties agreed to specifics upfront.

Indemnification

The framework for who pays if a rep and warranty turns out to be wrong. Typically capped at a percentage of the deal value and time-limited to 12 to 24 months.

Non-Compete / Restrictive Covenants

An agreement you sign at close that prevents you from opening a competing practice within a specified distance and time period.

Example: Two-year non-compete within 15 miles of the practice location. You cannot practice dentistry in that geography for two years, or must pay damages.

Things to verify: Radius and duration are negotiable. If you plan to keep working in the same market, negotiate carve-outs. If you plan to retire, this matters less.

The purpose of a non-compete is to protect the significant investment a buyer makes when acquiring a practice. That investment includes patient introduction, staff continuity, referral network access, and brand goodwill. Groups worth working with can explain their reasoning for the specific terms and are open to discussion within reasonable bounds. A conversation about non-competes at the LOI stage tends to build a stronger foundation than trying to renegotiate later.

Non-Solicit

Similar to a non-compete but focused on people. You cannot recruit your former staff to a new venture for a set period, typically 2 years.

Post-Close Terms

What happens after the deal closes.

Transition Period / Post-Close Services Agreement

The buyer usually wants you to keep working for 6 to 24 months after close to keep patients and staff comfortable with the transition. You are paid separately for this work, usually at a market-rate salary or per-day fee.

Management Services Organization (MSO)

The corporate entity that handles non-clinical operations for the practice after close. HR, billing, marketing, accounting, IT, procurement. The clinical practice remains a separate legal entity owned by dentists.

Management Fee

What the MSO charges the clinical practice for its services after close. Usually a percentage of collections. Typical range is 6 to 12 percent depending on services provided.

Example: Practice does $2.4M in collections. MSO management fee is 8 percent. That is $192K per year going to the MSO for support services.

Board Seat / Shareholder Governance

If you take rollover equity, you become a shareholder in the parent company. Depending on the group structure and your ownership stake, you may or may not have a formal seat at the table where decisions get made.

Things to verify: Ask how doctor shareholders are represented in governance. Is it a doctor-owned group where owners have real voting power? Or is it PE-controlled where doctors have minimal say?

Recap (Recapitalization)

What happens when the group you sold into eventually sells itself or takes on a new investor. This is where rollover equity holders "cash out" their second bite.

Example: Bluetree sells to a new PE partner in 5 years. Your rollover shares get converted to cash at the new valuation. If Bluetree grew, your shares are worth more than at close.

GET THIS AS A CHEAT SHEET
The Practice Owner's Terminology Cheat Sheet
Every term above, plus 15 more, with worked examples, the questions to ask any buyer, and the questions to ask yourself before you sign an LOI.
Free. No spam. We will follow up once if you request it.

Where Bluetree Sits (Honestly)

I lead business development for Bluetree. Standard disclosure: I am not neutral here.

We are a doctor-owned group actively looking for partnerships with orthodontic, pediatric, and oral surgery practices, alongside our continued general dentistry focus. Specialty partnerships are structured the same way our GP partnerships work: full acquisition with the doctor remaining as clinical leader, back-office handled by us, rollover equity in the doctor-owned parent company.

How our deals typically look:

  • Cash at close covers the majority of the deal value, usually 60% to 80% of the total.
  • The rest sits in rollover equity in our parent company, or a combination of equity and short-term holdback.
  • For practices with strong growth potential, we get creative with earnout structures to align on that growth so the seller shares in the upside they help create.

We walk every owner through the three-lens breakdown of any offer we make. We explain what our cash-at-close number is, what the rollover mechanics look like, what any earnout would trigger on, and what total realized value could look like under reasonable assumptions. Nothing is hidden. Nothing is inflated.

Whether specialty or general, we are honest about who fits us and who does not. If your practice does not fit our model, we will say so and often help you think through better alternatives.

If you want to walk through your specific practice, reach out. No obligation.